Gangloff Scott A. Insider Trades

Insider Trading History

Track insider trading activity for Gangloff Scott A.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Akero Therapeutics
Akero Therapeutics AKRO
Chief Technology Officer
Holding Value $0 0 shares
Last Trade
Dec 09, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$16.4M 299,579 shares
$54.65
$54.65
Akero Therapeutics
Akero Therapeutics AKRO
Chief Technology Officer
Holding Value $972k 17,784 shares
Last Trade
Aug 15, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$128k 2,600 shares
$49.38
$54.65
Akero Therapeutics
Akero Therapeutics AKRO
Chief Technology Officer
Holding Value $1.44M 26,351 shares
Last Trade
Aug 15, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$128k 2,600 shares
$49.38
$54.65
Akero Therapeutics
Akero Therapeutics AKRO
Chief Technology Officer
Holding Value $1.3M 23,751 shares
Last Trade
Jun 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16k 299 shares
$53.36
$54.65
Akero Therapeutics
Akero Therapeutics AKRO
Chief Technology Officer
Holding Value $1.28M 23,452 shares
Last Trade
Jun 18, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$46.5k 848 shares
$54.84
$54.65
Akero Therapeutics
Akero Therapeutics AKRO
Chief Technology Officer
Holding Value $4.03M 73,700 shares
Last Trade
Dec 16, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.15M 73,700 shares
$29.23
$54.65
Akero Therapeutics
Akero Therapeutics AKRO
Chief Technology Officer
Holding Value $12.3M 225,000 shares
Last Trade
Apr 29, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.41M 225,000 shares
$19.62
$54.65
Outlook Therapeutics- Warrants
Outlook Therapeutics- Warrants OTLKW
Svp, Development & Mfrg
Holding Value $3.56k 118,573 shares
Last Trade
Dec 21, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3k 40,000 shares
$0.08
$0.03
Outlook Therapeutics
Outlook Therapeutics OTLK
Svp, Development & Mfrg
Holding Value $202k 118,573 shares
Last Trade
Dec 21, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$94.1k 40,000 shares
$2.35
$1.70
Outlook Therapeutics
Outlook Therapeutics OTLK
Svp, Development & Mfrg
Holding Value $134k 78,573 shares
Last Trade
Nov 11, 2016 Sale (Open Market)Shares sold on the open market or in a private sale.
$140k 37,369 shares
$3.75
$1.70
Outlook Therapeutics- Warrants
Outlook Therapeutics- Warrants OTLKW
Svp, Development & Mfrg
Holding Value $2.36k 78,573 shares
Last Trade
Nov 11, 2016 Sale (Open Market)Shares sold on the open market or in a private sale.
$16.1k 37,369 shares
$0.43
$0.03
Outlook Therapeutics
Outlook Therapeutics OTLK
Svp, Development & Mfrg
Holding Value $0 0 shares
Last Trade
Nov 09, 2016 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$470k 115,942 shares
$4.05
$1.70
Outlook Therapeutics- Warrants
Outlook Therapeutics- Warrants OTLKW
Svp, Development & Mfrg
Holding Value $0 0 shares
Last Trade
Nov 09, 2016 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$49.6k 115,942 shares
$0.43
$0.03
Outlook Therapeutics
Outlook Therapeutics OTLK
Svp, Development & Mfrg
Holding Value $197k 115,942 shares
Last Trade
Nov 09, 2016 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$470k 115,942 shares
$4.05
$1.70
Outlook Therapeutics- Warrants
Outlook Therapeutics- Warrants OTLKW
Svp, Development & Mfrg
Holding Value $3.48k 115,942 shares
Last Trade
Nov 09, 2016 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$49.6k 115,942 shares
$0.43
$0.03

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up